Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Use of Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea in Adults With Intellectual and Developmental Disabilities.

Created on 05 Nov 2026

Authors

Aryan Shiari, Hussam Z Al-Sharif, Ali A Zaied, Adel S Zurob, Christopher D Wlliams

Published in

WMJ : official publication of the State Medical Society of Wisconsin. Volume 125. Issue 4. Pages 457-461.

Abstract

The objective of this study was to assess the safety, efficacy, and patient satisfaction of hypoglossal nerve stimulation (HNS) therapy as an alternative to continuous positive airway pressure therapy for obstructive sleep apnea in adults with intellectual and developmental disabilities (IDDs), including trisomy 21 and cerebral palsy.
We conducted an observational study of 4 adults with IDDs and moderate to severe obstructive sleep apnea who underwent implantation of an HNS device. Patient demographic characteristics, device usage, obstructive sleep apnea and daytime sleepiness outcomes, and patient satisfaction scores were retrospectively reviewed and analyzed.
The mean adherence rate was 92.3%. The mean [SD] pretreatment apnea-hypopnea index was 39.0 [16.7] events per hour, which decreased to 8.5 [4.7] event per hour after treatment, representing a mean [SD] reduction of 77.5% [12.9%]. Epworth Sleepiness Scale scores decreased in 2 patients, were unchanged in 1 patient, and increased in 1 patient. Patient-reported satisfaction was high, with mean [SD] scores of 5.0 [0.0] for comfort, ease of deactivation, and effectiveness and 4.5 [0.6] for ease of activation.
Treatment of obstructive sleep apnea with HNS was associated with decreased apnea-hypopnea index values and was well tolerated among adults with IDDs, suggesting that it may be a viable alternative to continuous positive airway pressure therapy for patients who cannot tolerate conventional treatment. However, the variable Epworth Sleepiness Scale findings and small sample highlight the need for larger studies with long-term follow-up to further evaluate the safety and effectiveness of HNS in this population.

PMID:
42981513
Bibliographic data and abstract were imported from PubMed on 05 Nov 2026.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement